Cell Line Genetics is the leading provider of stem cell characterization and multispecies quality assurance services and products specifically designed to ensure the genetics integrity and authentication of adult and pluripotent stem cell lines.
As a leader in the Stem Cell and Regenerative Medicine field CLG has the track record and technical expertise to meet the demanding needs of the leading universities and research institutes, as well as biotechnology and pharmaceutical companies worldwide.
Cell Line Genetics is an independent and privately owned company, not affiliated with any academic institutions, research institutes, or government-funded laboratories. Confidentiality is guaranteed.
Cell Line Genetics Inc. is a Proud Sponsor and Exhibitor of the 4th Annual Maryland Stem Cell Research Symposium
The 4th Annual Maryland Stem Cell Research Symposium will be held on September 6th at Townson University and will profile Maryland’s leading stem cell investigators and state funded projects. To date, the Maryland Stem Cell Research Fund has allocated over $78.8 million towards 218 stem cell research grants in just five years. Cell Line Genetics commends the Maryland Stem Cell Research Fund for their leadership and commitment to the field. We encourage you to join us for this special event! Learn More
Posted: 09/21/2011
Cell Line Genetics Inc. is a Proud Sponsor of the 4th NHLBI Symposium on Cardiovascular Regenerative Medicine
Cell Line Genetics is thrilled to support the National Heart, Lung, and Blood Institute's fourth Symposium on Cardiovascular Regenerative Medicine at the NIH Main Campus this October 4-5. The event brings together leading experts in basic stem cell biology, as well as clinical cardiovascular medicine, to discuss the emerging basic science, preclinical animal models and potential clinical applications. Learn More
Posted: 09/21/2011
Cell Line Genetics Inc. to Present at 2011 World Stem Cell Summit
Cell Line Genetics President and Chief Business Officer, Rob Herrera, is presenting at the 2011 World Stem Cell Summit - October 3-5 in Pasadena, CA - the stem cell and regenerative medicine field’s largest interdisciplinary event. Mr. Herrera along with representatives from Advanced Cell & Gene Therapy, NIST and ATCC will participate on day two's industry panel titled, “Commercial Stem Cell Standardization Solutions.” We look forward to seeing you in Pasadena! Learn More
Posted: 09/21/2011
Cell Line Genetics Inc. Exhibiting at Screening Stem Cells 2011
Visit the Cell Line Genetics team at Screening Stem Cells 2011. The event will be held on September 26-27 at the Sheraton Boston Hotel in the Back Bay area of Boston. Screening Stem Cells 2011 features an incredible scientific program consisting of 18 podium speakers, as well as thought-provoking poster sessions and an exhibition showcasing leading edge technologies. Come join CLG and the field's best in Boston! Learn More
Posted: 09/21/2011
Cell Line Genetics Exhibits at ISSCR 9th Annual Meeting in Toronto
Cell Line Genetics was a proud exhibitor of the International Society for Stem Cell Research Annual Meeting, the largest international interdisciplinary forum dedicated to stem cell science. This year, the 9th Annual Meeting was on held June 15 - 18, 2011, in Toronto, Ontario, Canada. The meeting brought together over 3,500 stem cell researchers to discuss emerging science in the evolving field of stem cell research. Learn More
Posted: 06/23/2011
Cell Line Genetics and Ambry Genetics Announce Exclusive Global Agreement For Sales of Ambry Genetics’ StemArray™ and Related Services
MADISON, Wisc., New York, NY and ALISO VIEJO, Calif. – June 15, 2011 - Cell Line Genetics, Inc., a leader in Stem Cell Quality Assurance services and products, and Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announced today an exclusive agreement under which Cell Line Genetics will sell the Ambry StemArray™ aCGH (array Comparative Genomic Hybridization) product and related services to its current customers as well as other companies and research institutions. Both companies believe this partnership will dramatically expand the availability of the Ambry StemArray and hasten its adoption in the stem cell and regenerative medicine market globally. Learn More
Posted: 06/15/2011
Cell Line Genetics Marks 7,500 Quality Assurance Cases in the Field of Stem Cell Research & Regenerative Medicine
MADISON, Wis. & NEW YORK--(BUSINESS WIRE)--Cell Line Genetics, Inc. (“CLG”), a leader in Stem Cell Quality Assurance (“QA”) services and products, announced today that it has performed QA services on over 7,500 stem cell samples. The company concurrently announced significant additions to both its management and scientific teams: Robert Margolin has been appointed to Director of Marketing, and the company expanded its research and product development team in Madison, Wisconsin. Learn More
Posted: 06/08/2011
Cell Line Genetics Honored as One of the 2011 “Wisconsin Companies to Watch”
MADISON, Wis. & NEW YORK--(BUSINESS WIRE)--Cell Line Genetics, LLC (“CLG”), a leader in Stem Cell Quality Assurance (“QA”) services and products, has been recognized as one of the thirty-three 2011 “Wisconsin Companies to Watch,” an awards program presented by the Wisconsin Entrepreneurs’ Network (WEN) with support from the Wisconsin SBDC Network and the Division of Entrepreneurship and Economic Development (DEED) at the University of Wisconsin-Extension in association with the Edward Lowe Foundation. Learn More
Posted: 05/20/2011
3rd Southeast Stem Cell Workshop at Vanderbilt University
The 3rd Annual Southeast Stem Cell Consortium Workshop was held July 22-23, 2010 at the Student Life Center at Vanderbilt University. CLG attended as a sponsor.
Learn More
Posted: 03/14/2011
CLG participates in the World Stem Cell Summit 2010 in Detroit
The 2010 World Stem Cell Summit was the largest multi-track stem cell conference produced to date, featured more than 150 speakers and 50 hours of in-depth science, business and society presentations.
Learn More
Posted: 03/12/2011